Skip to main content
SpringerLink
Log in

Clinical usefulness of alterations in sialic acid, sialyl transferase and sialoproteins in breast cancer

  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Sialic acid, the end moieties of the carbohydrate chains are biologically important and essential for functions of glycoconjugates and are reported to be altered in cancer patients. Two hundred and twenty five breast cancer (BC) patients, 100 patients with benign breast disease (BBD) and 100 healthy females (controls) were enrolled for the study. Eight hundred and twenty four follow-up samples of 225 breast carcinoma patients were also evaluated. The association of sialic acid forms, sialyltransferase and α-2–6 sialoproteins levels with presence and extent as well as prognosis of breast carcinoma was studied. Serum sialic acid forms and sialyltransferase revealed significantly elevated levels among untreated breast cancer patients as compared to the controls, patients with BBD as well as cancer patients in remission. Non-responders showed comparable levels of the markers with those found in breast cancer patients at the time of diagnosis. Higher levels of sialic acid forms at diagnosis were associated with poor prognosis. A positive correlation between serum levels of different forms of sialic acids and extent of malignant disease was observed. The changes in serum proteins with terminal α-2–6 sialic acid correlated well with alterations in the levels of sialic acid forms and sialyltransferase. Malignant tissues showed elevated levels of sialic acid and sialyltransferase as compared to surrounding normal tissues.

The results suggested potential utility of these markers in evaluation of clinical outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hakomori, S. (1989) Aberrant glycosylation in tumour and tumour-associated carbohydrate antigens. Adv. Cancer Res. 52, 257–331.

    PubMed  CAS  Google Scholar 

  2. Passaniti, A. and Hart, G.W. (1988) Cell surface sialylation and tumour cell metastatic potential of B16 melanoma variants correlates with their relative number of specific penultimate with oligosscharide structure. J. Boil. Chem. 263, 7591–7603.

    CAS  Google Scholar 

  3. Yogeeswaran, G. (1981) Metastatic potential is positively correlated with cell surface sialylation of cultured murine cell lines. Science 212, 1514–1516.

    Article  PubMed  CAS  Google Scholar 

  4. Singhal, A. and Hakomori, S. (1990) Molecular changes in carbohydrate antigens associated with cancer, Bioassays 12, 223–230.

    Article  CAS  Google Scholar 

  5. Rademacher, T.W., Parekh, R.B., and Dwek, R.A. (1988) Glycobiology. Annu. Rev. Biol. Chem. 57, 785–838.

    CAS  Google Scholar 

  6. Feijoo, C., Paez-de-la, Cadena, M. and Rodriguezberrocat, F.J. (1997) Sialic acid level in serum and tissue from colorectal cancer patients. Cancer Lett. 112, 155–160.

    Article  PubMed  CAS  Google Scholar 

  7. Paszkowaska, A., Berbec, H., Semczuk, A. and Cybulski, M. (1998) Sialic acid concentration in serum and tissue of endometrial cancer patients. Eur. J. Obstet. Gynecol. Reprod. Biol. 76, 211–215.

    Article  Google Scholar 

  8. Dall'olio, F. and Trere, D. (1993) Expression of alpha 2,6 sialylated sugar chain in normal and neoplastic colon tissues. Detection by digoxigenin conjugated sambucus nigra aglutinin. Eur. Jr. Histochem. 37, 257–265.

    Google Scholar 

  9. Marth, E., Flaschka, G. Stiegler S. and Mose, J. (1988) Sialic acid as a marker for differentiation between benign and malignant intracranial tumours. Clinica. Chimica. Acta. 176, 251–258.

    Article  CAS  Google Scholar 

  10. Kelm, S. and Schauer, R. (1997) Sialic acid in molecular and cellular interaction. Int. rev. cytol. 175, 137–240.

    Article  PubMed  CAS  Google Scholar 

  11. Gatchev, O., Rastam, L., Lindberg G., Gullberg, B., Eklund, G.A. and Tornberg, S. (1993) Tumours of the central nervous system and serum sialic acid concentration in men and women Br. J. Cancer 68, 425–427.

    PubMed  CAS  Google Scholar 

  12. Schauer, R. and Corfield, A.P. (1982) Occurance of sialic acids-chemistry, metabolism and function. In: Cell biology monographs, Schauer, R. (ed.). Springer Verlag, New York, 10, 5–50.

    Google Scholar 

  13. Vierbuchen, M.J., Fruectnicht, W., Brackrock, S., Kranse, K.T. and Zienkiewicz, T.J. (1995) Quantitative lectin histochemical and immunochemical studies on the occurance of alpha 2, 6-linked sialic acid residues in colorectal carcinomas. Relation to clinicopathological features. Cancer 76, 727–735.

    Article  PubMed  CAS  Google Scholar 

  14. Holmes, E., Osterander, G. and Hakomori, S. (1986) Biosynthesis of the sialyl-LeX determinant carried out by type-2 chain glycosphingolipids (IV 3 NeuAcIII3 FucnLc4, Vi3NeuAcV3FucnLc6 and Vi3 NeuAcIII3 V3 Fuc2 nLc6) in human lung carcinoma cell lines. J. Biol. Chem. 261, 3737–3743.

    PubMed  CAS  Google Scholar 

  15. UICC TNM classification of malignant tumours. (1980) UICCTechnical Report series. Seller A.H. (ed). 1st edition, 7.

  16. Miller, A.B., Hoogstraten, B., Staquet, M. and Winkler, A. (1981) Reporting results of cancer treatment. Cancer 47, 207–214.

    Article  PubMed  CAS  Google Scholar 

  17. Skoza, L. and Mohos, S. (1976) Stable thiobarbituric acid chromophore with dimethyl sulfoxide. Application to sialic acid assay in analytical De-O-acetylation. Biochem. J. 159, 457–462.

    PubMed  CAS  Google Scholar 

  18. Warren, L., Buck, C.A. and Tuszynski, G.P. (1978) Glycopeptide changes and malignant transformetios: A possible role for carbohydrate in malignant behaviour. Biochim. Biophys. Acta. 516, 97–127.

    PubMed  CAS  Google Scholar 

  19. Winzler, R.J. (1955) Determination of serum glycoproteins. In: Methods of biochemical analysis. Vol. 2. New York; Intersciences Publishers 279–311.

    Chapter  Google Scholar 

  20. Kessel D. and Allen, J. (1975) Elevated plasma sialytransferase in the cancer patients. Cancer Res. 35, 670–672.

    PubMed  CAS  Google Scholar 

  21. Thompson, S. and Turner, G.A. (1987) Elevated levels of abnormally fucosylated heptoglobins in cancer sera. Br. J. Cancer 56, 605–610.

    PubMed  CAS  Google Scholar 

  22. Noursis, M.J. (1996) SPSS for windows. SPSS Advanced stastic release 7.5; SPSS Inc. Chicago.

    Google Scholar 

  23. Kaplan, E.L. and Meier, P. (1958) Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 34, 457–481.

    Article  Google Scholar 

  24. Cox, A.R. (1972) Regression analysis model and life table. J. Stat. Soc. (Br.) 34, 187–198.

    Google Scholar 

  25. Patel, P.S., Baxi, B.R., Adhvaryu, S.G. and Balar, D.B. (1990) Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma. Anticance. Res. 10, 1071–1074.

    CAS  Google Scholar 

  26. Patel, P.S., Raval, G.N., Rawal, R.M., Patel, G.H., Balar, D.B., Shah, P.M. and Patel, D.D. (1995) Comparision between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer. Neoplasma 42, 53–56.

    Google Scholar 

  27. Raval, G.N., Parekh, L.J., Patel, M.M., Patel, P.S., Rawal, R.M., Balar, D.B. and Patel, D.D. (1997) Role of sialic acid and alkaline DNase in breast cancer. The Int. Jr. Biol. Markers 12, 61–67.

    CAS  Google Scholar 

  28. Kobata, A. and Takasaki, S. (1993) Structural characterization of oligo-saccharides from glycoproteins. In: Glycobiology: A practical approach. Fukuda, M. and Kobata, A. (eds.). Oxford University Press, New York, 165–85.

    Google Scholar 

  29. Varki, A. (1993) Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 3, 97–130.

    Article  PubMed  CAS  Google Scholar 

  30. Baxi, B.R., Patel, P.S., Adhvaryu, S.G. and Dayal, P.K. (1991) Usefulness of serum glycoconjugates in precancerous and cancerous disease of the oral cavity Cancer 67, 135–140.

    Article  PubMed  CAS  Google Scholar 

  31. Sashikantha, M.C. and Rao, B.B. (1994) Study of serum fucose and serum sialic acid levels in oral squmous cell carcinoma. Ind. J. Dent. Res. 5, 119–124.

    Google Scholar 

  32. Gosh, M. and Nayak, B.R. (1991) Serum sialic acid, fucose, sialic acid/fucose ratio as tumour marker in oral cancer. Annals of Densitry 50, 33–35.

    Google Scholar 

  33. Ogoshi, K., Miyaji, M. Nakamura, K., Kondoh, Y., Makuuchi, H. and Tajima T. (1997) Immuntherapy and combined assay of serum level of CEA and acute phase reactants. Cancer Immunol. Immunotherapy 46, 14–20.

    Article  Google Scholar 

  34. Fernandez-Rodriguez, J., Paez-de-la-cadena, M. and Martinez-zorzano, V.S. (1997) Fucose level in serum and in tumor of colorectal adenocarcinoma patients. Cancer Lett. 121, 147–53.

    Article  PubMed  CAS  Google Scholar 

  35. Patel, P.S., Raval, G.N., Patel, M.M., Balar, D.B. and Patel, D.D. (1996) Electrophoretic pattern of serum glycoproteins on polyacrylamide disc gel in patients with breast cancer. Anticancer Res. 16, 2089–2094.

    PubMed  CAS  Google Scholar 

  36. Alhadeff, J.A. (1989) Malignant cell glycoproteins and glycolipids. CRC Crit. Rev. in Oncol. Hematol. 9, 37–107.

    Article  CAS  Google Scholar 

  37. Feizi, T and Childs, R.A. (1987) Carbohydrates as antigenic determinants of glycoproteins. Biochem. J. 245, 1–11.

    PubMed  CAS  Google Scholar 

  38. Miles, D.W., Happerfield, L.C., Smith, P., Gillibrand, R., Bobrow, L.G., Gregory W.M. and Rubens, R.D. (1994) Expression of sialyl Tn predicts the effect of adjuvant chemotherapy in node positive breast cancer. Br. J. Cancer 70, 1272–1275.

    PubMed  CAS  Google Scholar 

  39. Muryama, T., Zuber, C., Seelentag, W.K., Li, W.P., Kemmner, W., Heiz, P.U. and Roth, J.L. (1997) Colon carcinoma glycoprotein carrying alpha 2,6-linked sialic acid reactive with sambucus nigra agglutinin are not constitutively expressed in normal human colon mucosa and are distinct from sialyl Tn antigen Int. J. Cancer 70, 575–581.

    Article  Google Scholar 

  40. Gessner, P., Riedl, S., Quentmaier, A. and Kemmno, W. (1993) Enhanced activity of CMP-NeuAc: Gal beta 1-4GlcNAc:alpha 2–6 Sialyltransferase in metastasizing tumour tissue and serum of tumour patients. Cancer Lett. 75, 143–149.

    Article  PubMed  CAS  Google Scholar 

  41. Shimada, I., Shoji, M., Futu-suya, R., Katoh, T., Kominato, Y., Sakamoto, T. and Fujikura, T. (1995) Elevation of ratio of urinary N-acetyl Neuraminlactose to free sialic acids in some advanced cancer patients. J. Gastroentrol. 75, 143–149.

    Google Scholar 

  42. Lileng, R., Tved, K., Nesland, J.M., Reed, W., Erikstein, B.K. and Funderud, S. (1993) CDW75 antigen expression in breast cancer. Pathol. Res. Pract. 189, 394–398.

    Google Scholar 

  43. Yamamoto, H., Kaneko, Y., Vandermulan, D., Kersey, D., Mkrdichian, E., Leestma, J. and Moskal, J.R. (1995) The expression of CMP-NeUAc: Gal beta 1,4 Glc Nac, alpha 2,6 sialyltransferase (E.C 2.4.99.1) the glycoprotein bearing alpha 2,6-linked sialic acids in human brain tumours. Glycoconjugate J. 12, 848–856.

    Article  CAS  Google Scholar 

  44. Dao, T.L., Ip, C. and Patel, J. (1980) Serum sialyltransferase and 5′nucleotidase as reliable biomarkers in women with breast cancer. J. Natl. Cancer. Invst. 65, 529–534.

    CAS  Google Scholar 

  45. Nakata, B., Chung, K.H., Maguruma, K., Yamashita, Y., Inoue, T., Matsuoka, T., Onoda, N., Kato, Y., Sakurai, M. and Sowa, M. (1998) Changes in tumor marker levels as a predictor of chemotherapeutic effect in patients with gastric carcinoma. Cancer 83, 19–24.

    Article  PubMed  CAS  Google Scholar 

  46. Suer, S., Sonmez, H., Karaaslan, I., Baloglu, H. and Kokoglu, E. (1996) Tissue sialic acid and fibronectin levels in human prostatic cancer. Cancer Lett., 99, 135–137.

    Article  PubMed  CAS  Google Scholar 

  47. Wang, J.W., Ambros, R.A., Weber, P.B. and Rosano, T.G. (1995) Fucosyl transferase and α-L fucosidase and fucose level in normal and malignant endometrial tissue. Cancer Res. 55, 3654–3658.

    PubMed  CAS  Google Scholar 

  48. Akamatsu, S., Yazawa, S., Tachikawa, T., Furuta, T., Okaichi, Y., Nakamura, T., Asao, T. and Nagamachi, Y. (1996) Alpha 2–3 sialyltransferase associated with the synthesis of CA19-9 in colorectal tumours. Cancer 77, 1694–1700.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biochemistry Research Division, The Gujarat Cancer & Research Institute, Asarwa, 380 016, Ahmedabad, India

    G. N. Raval, D. D. Patel, F. P. Jha, R. N. Sainger & P. S. Patel (In-Charge)

  2. Department of Biochemistry, Faculty of Science, M.S. University of Baroda, Vadodara, India

    L. J. Parekh

Authors
  1. G. N. Raval
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. J. Parekh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. D. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. P. Jha
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. N. Sainger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. S. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. S. Patel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raval, G.N., Parekh, L.J., Patel, D.D. et al. Clinical usefulness of alterations in sialic acid, sialyl transferase and sialoproteins in breast cancer. Indian J Clin Biochem 19, 60–71 (2004). https://doi.org/10.1007/BF02894259

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02894259

Key Words

Search

Navigation